Filing Details
- Accession Number:
- 0001209191-23-056353
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-11-21 17:59:28
- Reporting Period:
- 2023-11-18
- Accepted Time:
- 2023-11-21 17:59:28
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1831915 | Cytek Biosciences Inc. | CTKB | Laboratory Analytical Instruments (3826) | 472547526 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1874041 | Ming Yan | C/O Cytek Biosciences, Inc. 47215 Lakeview Boulevard Fremont CA 94538 | Chief Technology Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-11-18 | 1,981 | $0.00 | 7,777,943 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-11-18 | 772 | $5.98 | 7,777,171 | No | 4 | F | Direct | |
| Common Stock | Acquisiton | 2023-11-18 | 7,363 | $0.00 | 7,784,534 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-11-18 | 2,431 | $5.98 | 7,782,103 | No | 4 | F | Direct | |
| Common Stock | Disposition | 2023-11-20 | 20,000 | $6.03 | 7,762,103 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | M | Direct | |
| No | 4 | F | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Restricted Stock Units | Disposition | 2023-11-18 | 1,981 | $0.00 | 1,981 | $0.00 |
| Common Stock | Restricted Stock Units | Disposition | 2023-11-18 | 7,363 | $0.00 | 7,363 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 17,180 | No | 4 | M | Direct | ||
| 98,179 | No | 4 | M | Direct |
Footnotes
- Each Restricted Stock Unit (the "RSU Award") represents a contingent right to receive one share of the Issuer's common stock.
- Represents the number of shares withheld by and surrendered to the Issuer on November 18, 2023, to satisfy tax withholding obligations that arose in connection with the vesting of the RSU Award.
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 17, 2022.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.88 to $6.11, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- The shares subject to the RSU Award shall vest quarterly over four years, with 4/48th of the total shares underlying the RSU Award vesting on May 18, 2022 and 3/48th of the total shares underlying the RSU Award vesting each subsequent quarter thereafter on August 18, November 18, February 18 and May 18.
- The shares subject to the RSU Award shall vest over four years with 2/48 of the total shares underlying the RSU Award vesting on May 18, 2023 and each May 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on August 18, 2023 and each August 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on November 18, 2023 and each November 18 thereafter; and 4/48 of the total shares underlying the RSU Award vesting each March 10, 2024 and each March 10 thereafter, until fully vested.
Billionaire Hedge Funds
